Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two years into reverse vaccinology.

Jeannette Adu-Bobie1, Barbara Capecchi, Davide Serruto

  • 1IRIS, Chiron SpA, Via Fiorentina 1, 53100, Siena, Italy.

Vaccine
|January 18, 2003
PubMed
Summary

Reverse Vaccinology offers a faster, in silico approach to vaccine development by predicting antigens computationally. This genomic strategy overcomes limitations of traditional methods for challenging human pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GMMA as delivery system for Klebsiella pneumoniae O-antigens and K-antigens.

Scientific reports·2026
Same author

Perspective on the pathogenic Neisseria: milestones, challenges, and future directions.

NPJ vaccines·2026
Same author

Editorial: Expert opinions: save the microbes to save the planet.

Frontiers in microbiology·2025
Same author

Temporal and Spatial Profiling of <i>Escherichia coli</i> O157:H7 Surface Proteome: Insights into Intestinal Colonisation Dynamics In Vivo.

Proteomes·2025
Same author

Global antimicrobial resistance-The ostrich's head is in the sand.

PLoS biology·2025
Same author

Correction: Intestinal pathogenic <i>Escherichia coli</i>: insights for vaccine development.

Frontiers in microbiology·2025

Area of Science:

  • Vaccinology
  • Genomics
  • Infectious Disease

Background:

  • Traditional vaccine development relies on pathogen cultivation and biochemical analysis, which is time-consuming and often unsuccessful for many pathogens.
  • Conventional methods include live-attenuated and subunit vaccines, each with limitations in efficacy and safety for certain diseases.

Observation:

  • Genomic approaches enable in silico prediction of all potential antigens, irrespective of their abundance.
  • This bypasses the need for in vitro cultivation and complex biochemical dissection of microorganisms.

Findings:

  • Reverse Vaccinology, a novel genomic strategy, revolutionizes vaccine design by computationally identifying and selecting antigens.
  • The Neisseria meningitidis serogroup B vaccine project exemplifies the successful application of Reverse Vaccinology.

Related Experiment Videos

  • This approach has been extended to develop vaccines against other challenging human pathogens.

    • Implications:

    • Reverse Vaccinology accelerates vaccine development pipelines for previously intractable diseases.
    • It offers a more efficient and potentially safer alternative to traditional vaccine research methods.
    • This strategy holds significant promise for addressing global health challenges posed by infectious agents.